PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsQilu Pharmaceuticals
Qilu Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AbirateroneAbiraterone2019-09-272027-2038
BortezomibBortezomib2022-05-022032-2042
CefazolinCefazolin2015-12-28
CefepimeCefepime2016-02-01
CeftriaxoneCeftriaxone2016-06-29
DaptomycinDaptomycin2021-08-242028-2041
DecitabineDecitabine2021-04-122028-2030
ExemestaneExemestane2020-04-13
Fosaprepitant dimeglumineFosaprepitant dimeglumine2020-09-08
—
ImatinibImatinib2022-06-21
IrinotecanIrinotecan2016-05-032025-2036
OlanzapineOlanzapine2016-01-272025-2041
Olmesartan medoxomilOlmesartan medoxomil2019-01-10
—
1
2
3
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Gefitinib
Tenofovir disoproxil
Irinotecan
Antithrombin iii
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use